Larotrectinib Sulfate
|
|
- CAS-Nr.
- 1223405-08-0
- Englisch Name:
- Larotrectinib Sulfate
- Synonyma:
- LOX-101;Loxo-101(S);LOX-101(sulfate);ARRY 470) sulfate;Larotinib sulfate;LOXO-101 (sulfate);Larotrectinib sulfate;Larotrectinib(LOXO 101;Larotrectinib sulphate;ARRY-470, Larotrectinib
- CBNumber:
- CB93067010
- Summenformel:
- C21H24F2N6O6S
- Molgewicht:
- 526.52
- MOL-Datei:
- 1223405-08-0.mol
|
Larotrectinib Sulfate Eigenschaften
- storage temp.
- Store at -20°C
- L?slichkeit
- ≥18.47 mg/mL in DMSO; ≥2.14 mg/mL in EtOH; ≥29.65 mg/mL in H2O
- Aggregatzustand
- solid
- Farbe
- Light yellow to brown
- Stabilit?t:
- Hygroscopic
- InChIKey
- PXHANKVTFWSDSG-RZOMTXEQNA-N
- SMILES
- S(O)(O)(=O)=O.FC1C=CC(F)=CC=1[C@H]1CCCN1C1C=CN2N=CC(NC(N3C[C@@H](O)CC3)=O)=C2N=1 |&1:13,29,r|
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
|
|
Sicherheit |
P261 |
Einatmen von Staub vermeiden. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
Larotrectinib Sulfate Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
LOXO-101 (sulfate) (or Larotrectinib Sulfate) is an oral potent and selective ATP-competitive inhibitor of tropomyosin receptor kinases (TRK).
Verwenden
Larotrectinib Sulfate is a potent and selective oral ATP-competitive inhibitor of tropomyosin receptor kinases (TRK).
Mechanism of action
Larotrectinib sulfate functions as an inhibitor of TRKs including TRKA, B, and C. In in vitro and in vivo tumor models, larotrectinib demonstrated anti-tumor activity in cells with constitutive activation of TRK proteins resulting from gene fusions, deletion of a protein regulatory domain, or in cells with TRK protein overexpression. Larotrectinib had minimal activity in cell lines with point mutations in the TRKA kinase domain, including the clinically identified acquired resistance mutation, G595R. Point mutations in the TRKC kinase domain with clinically identified acquired resistance to larotrectinib include G623R, G696A, and F617L.
Larotrectinib Sulfate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
4H-Pyrazolo[1,5-a]pyrimidin-5-one
(S)-3-Hydroxypyrrolidine
5-(2,5-difluorophenyl)-3,4-dihydro-2H-pyrrole
3-nitropyrazolo[1,5-a]pyrimidin-5(4H)-one
LOXO-101
(S)-3-Hydroxypyrrolidine hydrochloride
(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine
(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine
(2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINE
2-Brom-1,4-difluorbenzol
Downstream Produkte
Larotrectinib Sulfate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 185)Lieferanten
- LOXO-101 (sulfate)
- (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate (1:1)
- Larotrectinib/LOXO 101/ARRY 470 sulfate
- (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate
- ARRY 470) sulfate
- Larotrectinib sulfate
- Larotrectinib(LOXO 101
- Larotrectinib (LOXO-101) sulfate
- 1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-, sulfate (1:1)
- ARRY-470, Larotrectinib
- LOX-101
- Loxo-101(S)
- LOX-101(sulfate)
- Larotrectinib sulfate(LOXO101)
- (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide sulfate
- Larotrectinib sulfate salt
- 2H4]-Larotrectinib sulfate salt
- LOXO-101 sulfate|||Larotrectinib (LOXO-101) sulfate|||Larotrectinib|||LOXO-101 (sulfate)|||ARRY-470|||ARRY-470 (sulfate)
- Larotinib sulfate
- Larotrectinib sulfate, 10 mM in DMSO
- Larotrectinib sulphate
- 1223405-08-0
- C21H22F2N6O2H2SO4
- C21H24F2N6O6S
- API
- LOXO-101